![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 37840-37844, December 31, 1999
,
From the Department of Life Sciences, Graduate School of Arts and
Sciences, University of Tokyo, Komaba, Tokyo 153-8902,
Department of Physics, Faculty of Science and Technology,
Keio University, Yokohama 223-8522, and § Department of
Chemistry, Asahikawa Medical College, Asahikawa,
Hokkaido 078-8510, Japan
| |
ABSTRACT |
|---|
|
|
|---|
One of the putative actin-binding sites of
Dictyostelium myosin II is the In the absence of ATP, actin and myosin form a stable "rigor"
complex, which is held together mainly by strong hydrophobic interactions. A three-dimensional reconstruction of electron
microscopic images of the rigor complex of actin and myosin subfragment
1 (S1)1 revealed that S1 is
in contact with actin at several sites (1, 2). One of the putative
actin-binding sites of S1 is the The second putative actin-binding site is located at the tip of the
-strand-turn-
-strand
structure
(Ile398-Leu-Ala-Gly-Arg-Asp403-Leu-Val405),
the "myopathy loop," which is located at the distal end of the
upper 50-kDa subdomain and next to the conserved arginine (Arg397), whose mutation in human cardiac myosin results in
familial hypertrophic cardiomyopathy. The myopathy loop contains the
TEDS residue (Asp403), which is a target of the heavy-chain
kinase in myosin I. Moreover, the loop contains a cluster of
hydrophobic residues (Ile398, Leu399,
Leu404, and Val405), whose side chains are
fully exposed to the solvent. In our study, the myopathy loop was
deleted from Dictyostelium myosin II to investigate its
functional roles. The mutation abolished hydrophobic interactions of
actin and myosin in the strong binding state during the ATPase cycle.
Association of the mutant myosin and actin was maintained only through
ionic interactions under these conditions. Without strong hydrophobic
interactions, the mutant myosin still exhibited motor functions,
although at low levels. It is likely that the observed defects resulted
mainly from a loss of the cluster of hydrophobic residues, since
replacement of Asp403 or Arg402 with alanine
generated a mutant with less severe or no defects compared with those
of the deletion mutant.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-strand-turn-
-strand structure
(Ile398-Leu-Ala-Gly-Arg-Asp403-Leu-Val405,
in the case of Dictyostelium myosin II) located at the
distal end of the upper 50-kDa subdomain (see Fig. 1) (3, 4).
Involvement of this
-turn-
structure in the actin-myosin
interaction has been implied by two findings. First, mutation of
Arg403 (equivalent to Arg397 in
Dictyostelium myosin II) to glutamine in human cardiac
myosin is the cause of familial hypertrophic cardiomyopathy (5) (thus, this
-turn-
structure is designated as the myopathy loop). In fact, R403Q mutation in cardiac myosin (6) and R397Q mutation in
Dictyostelium myosin II (7) generated mutants with lower affinity to actin, suggesting the involvement of this conserved arginine residue in the actin-myosin interaction. Second, a threonine or serine residue of myosin I, whose location corresponds to a residue
at the tip of the myopathy loop (Asp403 in
Dictyostelium myosin II), is phosphorylated by a myosin
heavy-chain kinase (8). This phosphorylation is required for the full
activation of the actin-activated ATPase activity of myosin I. In the
case of myosin II, however, the residue is glutamate or aspartate as in
Dictyostelium myosin II (TEDS rule (9), T or S in myosin I,
and E or D in myosin II). In addition to this TEDS residue, the
myopathy loop contains a cluster of hydrophobic residues
(Ile398, Leu399, Leu404, and
Val405) whose bulky side chains are fully exposed to the
solvent (see Fig. 1), as if ready to interact with hydrophobic residues
on actin.
-helix-loop-
-helix structure at the distal end of the lower
50-kDa subdomain, and it contains conserved hydrophobic residues (Fig.
1). Some of the hydrophobic side chains
are fully exposed to the solvent and are likely to be in contact with
hydrophobic residues located between subdomain 1 and subdomain 3 of
actin (2). These two hydrophobic actin-binding sites may be
cooperatively involved in the rigor binding of actin and myosin in the
absence of ATP as well as in their rigor-like binding in the presence of ADP, i.e. in the strong binding during the ATP hydrolysis
cycle.

View larger version (54K):
[in a new window]
Fig. 1.
Actin binding sites on myosin. The
crystal structure of the motor domain of Dictyostelium
myosin II with MgADP/Vi (shown as a space-filling model in
purple) is shown as green strands. The deleted
residues from Ile398 to Val405 as well as
Arg397 are shown as space-filling models:
Arg397 in orange, hydrophobic residues in
yellow, Arg402 in blue,
Asp403 in green, and Ala400 and
Gly401 in cyan. Note that a dipeptide (AG) was
used as a linker to fill the gap after deletion. The second hydrophobic
binding site at the end of the lower 50-kDa subdomain is shown in
red. The 50-kDa-20-kDa loop as the ionic interaction site is
shown in magenta. a, the molecule is shown in an
orientation in which the actin binding surface is located at its back.
b, the molecule is rotated 180 degrees horizontally.
The third putative site is the 50kDa-20kDa junction, a flexible loop easily recognized in almost all members of the myosin family (10). This loop, rich in basic residues and glycine residues, seems to be in contact with acidic residues of actin to form ionic bonds (1, 2, 11, 12). These ionic bonds are a dominant factor in maintaining the actin-myosin association in the weak-binding state during ATP hydrolysis.
Dictyostelium discoideum cells have only one copy of the
heavy-chain gene of myosin II (13). Disruption of the gene generates Dictyostelium myosin-null cells with specific phenotypic
defects (14, 15). The introduction of a mutant heavy-chain gene into these myosin-null cells generates transformants expressing the mutant
myosin in place of the wild type. Using this Dictyostelium expression system developed by Spudich and co-workers (16-21), we
investigated how the myopathy loop of Dictyostelium myosin II is involved in the actin-myosin association and the motor functions of myosin.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Construction and Expression of Mutant Myosin and S1-- The myopathy loop (Ile398-Leu-Ala-Gly-Arg-Asp403-Leu-Val405) was replaced with a dipeptide (AG) by site-directed mutagenesis of the heavy-chain gene of Dictyostelium myosin II (provided by Dr. James A. Spudich, Stanford University). As a result of this mutation, six residues (Ile398, Leu399, Arg402, Asp403, Leu404, and Val405) were deleted from the heavy chain. Arg402 or Asp403 was also changed to alanine by site-directed mutagenesis. These mutant heavy-chain genes were ligated to the Dictyostelium actin-15 promoter and actin-6 terminator to drive their expression in Dictyostelium cells. They were finally inserted into a multicopy extrachromosomal vector, pBIG. Plasmids carrying these mutant heavy-chain genes were electroporated into Dictyostelium myosin-null cells in which the myosin-II heavy-chain gene had been knocked out by means of homologous recombination (15). Dictyostelium cells transformed by electroporation were selected in a medium supplemented with 20 µg/ml G418 on plastic dishes for a week.
The truncated myosin heavy-chain genes corresponding to wild-type and mutant S1 s were constructed as follows. The heavy chain was truncated at Glu836 by introducing a stop codon at the corresponding location of the heavy-chain gene. After fusing the actin-15 promoter and actin-6 terminator, the S1 gene was inserted into a multicopy vector, PTIKLOE (provided by Dr. TaroUyeda, National Institute for Advanced Interdisciplinary Research, Japan), which carries the essential and regulatory light-chain genes (22, 23). The light-chain genes (provided by Dr. Rex L. Chisholm, Northwestern University) were fused to the actin-15 promoter to achieve high level expression. A histidine tag (His6) was attached at the N terminus of the regulatory light chain for easier purification of S1 by inserting corresponding synthetic oligonucleotides between the start codon and the coding sequence of the light chain. The resulting transformation vector was introduced into Dictyostelium AX2 cells. The transformants were selected as above.
Phenotypes of the Transformed Cells-- Growth rates were measured by determining the number of cells cultured in suspension. The incubator was shaken at 150 rpm and 22 °C. The development of transformed cells was examined on an agar plate covered with a lawn of Escherichia coli cells. Dictyostelium cells (1.2 × 104) were suspended in 10 mM Tris-Cl, pH 7.5, and then spotted onto the bacterial lawn. When the bacterial lawn had been cleared of bacterial cells by the Dictyostelium cells, the Dictyostelium cells entered the developmental stage.
Protein Purification-- Phosphorylated myosin was prepared as described previously (24, 25). Wild-type or mutant S1 was prepared as described for myosin with modifications. S1 was extracted from transformed Dictyostelium cells and precipitated as actoS1 after dialysis against a solvent comprising 50 mM NaCl, 10 mM MOPS, pH 7.4, and 2 mM MgCl2. S1 was then extracted from the precipitate with a solvent composed of 10 mM MOPS, pH 7.4, 0.25 M NaCl, 7 mM MgCl2, and 5 mM ATP. The extract was directly applied to the nickel nitrilotriacetic acid column (Qiagen). After the column was washed with one column volume of the above solvent supplemented with 1 mM ATP, S1 was eluted with a linear gradient of imidazole, pH 7.4, from 10 mM to 0.5 M. The eluted protein was dialyzed against a solvent composed of 50 mM NaCl, 10 mM MOPS, pH 7.4, and 2 mM MgCl2. It was centrifuged at 100,000 × g for 30 min (Beckman TL100) before use. Relative concentrations of the proteins were determined by Protein Assay Reagent (Pierce).
ATPase and in Vitro Motility Assays-- ATPase activities were measured as described (7, 24). In vitro motility assays were performed in the presence of 0.2% or 0.7% methylcellulose as described (12, 26, 27). Force exerted on an actin filament was measured as described (28).
Fast Kinetics-- Time courses of mant-ATP binding or mant-ADP release to and from wild-type or mutant S1 were followed as described (29) by a stopped-flow apparatus with a fluorescence detector (Applied Photophysics SX18MV).
Actin-S1 Binding in the Absence of Nucleotide or in the Presence of ADP-- Varying amounts of wild-type or mutant S1 were mixed with a fixed amount of pyrene-labeled F-actin (0.25 µM) (30) in 50 mM NaCl, 10 mM MOPS, pH 7.4, and 2 mM MgCl2 or in this solvent supplemented with 1 mM ADP. Fluorescence measurements were performed at 25 °C with a Perkin-Elmer LS50B luminescence spectrophotometer with excitation at 365 nm and emission at 410 nm.
For pelleting experiments, varying amounts of F-actin were mixed with a
fixed amount of wild-type or mutant S1 (final concentration, 1.5 µM) in either 50 mM NaCl, 10 mM
MOPS, pH 7.4, and 2 mM MgCl2 or in 0.5 M NaCl, 10 mM MOPS, pH 7.4, and 2 mM MgCl2. The mixture was centrifuged at 15 min
at 4 °C (Beckman TL100). The supernatant and precipitate were
separated and analyzed by SDS gel electrophoresis to determine the
relative amount of S1 coprecipitated with F-actin.
| |
RESULTS |
|---|
|
|
|---|
Construction of Mutant Myosins and Their Subfragments--
A short
stretch of the heavy chain of Dictyostelium myosin II
spanning residues 398-405 (ILAGRDLV) was deleted, and the gap was
connected by a dipeptide (AG). This mutant was designated as
mutant. Since the residues at the gap are in contact with each other in
the three-dimensional structure of the motor domain of
Dictyostelium myosin II (4, 31), they can be connected with
the dipeptide without distorting the conformation around the deleted
site, as shown below. The sequence ILAGRDLV was replaced with AG, and
therefore, the mutation actually removed 6 amino acid residues
(Ile398, Leu399, Arg402,
Asp403, Leu404, and Val405). Two
point mutations, R402A and D403A, were also introduced into
Dictyostelium myosin II to discriminate the effects of the removal of charged side chains from those of hydrophobic side chains.
These mutants were expressed as full-length myosins or their soluble,
single-headed subfragments (subfragment 1 or S1) in
Dictyostelium cells.
Disruption of the Rigor Binding of Actin and Myosin--
Effects
of mutations on the actin-myosin interaction in the absence of ATP,
i.e. under the rigor conditions, were examined by using S1
and pyrene-labeled F-actin (30). As shown in Fig. 2A, the pyrene fluorescence
was quantitatively quenched upon the addition of wild-type S1, an
indication that the rigor complex was formed. When
S1 was mixed
with pyrene-labeled actin, however, no quenching was observed at the
concentrations examined (Fig. 2A). To examine the possibility that
S1 bound to actin without quenching the pyrene fluorescence, the
binding of actin and S1 was directly determined by pelleting
experiments (Fig. 3). In the absence of
ATP, wild-type S1 was coprecipitated with F-actin quantitatively by
ultracentrifugation. Unlike the wild type,
S1 remained in the
supernatant until a large excess of actin was added, indicating that it
actually lost tight binding with actin, as expected from the
fluorescence measurements. From the pelleting experiments, the
dissociation constant of
S1 and actin was calculated to be ~5
µM, whereas that of wild-type S1 and actin was
approximately 10 nM (32). This weak interaction of
S1
and actin in the absence of ATP was completely abolished when 0.5 M NaCl was included in the solvent (Fig. 3), indicating
that this binding was dominated by ionic interactions even in the
absence of ATP. Contrary to the case of
S1, the tight binding of
wild-type S1 and actin was not affected in a high ionic strength
solvent, as previously shown. It is very likely that the loss of
hydrophobic interactions between
S1 and actin resulted from a loss
of hydrophobic side chains in the myopathy loop, not from a loss of
charged side chains of Asp403 and Arg402, since
R402A or D403A S1 bound to actin as tightly as the wild type (Fig.
2A). These results suggest that the hydrophobic residues in
the myopathy loop are involved in the interface to actin in the rigor
state.
|
|
To examine if the myopathy loop is also involved in the interface to
actin in the presence of ADP, the pyrene-actin was titrated with
wild-type and mutant S1s (Fig. 2B). When wild-type S1 was added to pyrene-actin in the presence of 1 mM MgADP, the
rigor-like tight association of actin and S1 was observed, although the
affinity was lower than that in the absence of nucleotide. The addition of R402A or D403A S1 also resulted in association to actin with slightly lower affinity than that of the wild type, indicating some
contribution of these charged residues to the binding with actin in the
presence of ADP. The addition of
S1, however, resulted in only
slight quenching of the pyrene fluorescence at the concentrations examined here, showing that
S1 lost the rigor-like association with
actin in the presence of ADP. Thus, deletion of the myopathy loop,
especially deletion of the hydrophobic residues in the loop, abolished
both the rigor binding in the absence of nucleotide and the rigor-like
binding in the presence of ADP. The results indicate that the myopathy
loop contributes to the interface with actin both in the absence of
nucleotide and in the presence of ADP.
Effect of Mutations on the Enzymatic Properties of Myosin in the
Absence of Actin--
We examined the effects of mutations on the
enzymatic properties of myosin to know if structural changes induced by
the mutations were confined to the mutation site. First, a steady-state
rate of hydrolysis of MgATP by wild-type or mutant S1 was determined by
observing intrinsic tryptophan fluorescence (33). As shown in Table
I, the basal MgATPase activities of
,
R402A, and D403A S1s were very similar to those of the wild type,
indicating that these mutations did not disturb the ATPase site. To
further support this notion, we measured the rate of binding of
mant-ATP to wild-type or mutant S1 by means of the enhancement of
fluorescence of the mant moiety upon binding (29). The rate of release
of mant-ADP from wild-type or mutant S1 was also determined by the
decrease in fluorescence of the mant moiety upon addition of excess ATP (29). All of these measurements, summarized in Table I, showed that no
significant difference was detected between wild-type and mutant S1s.
Thus, it is likely that conformational changes induced by the
,
R402A, and D403A mutations were confined to the mutation site.
|
Effect of the Deletion of the Myopathy Loop on the in Vitro
Functions of Myosin--
Although the
mutation did not affect the
enzymatic properties of myosin in the absence of actin, as mentioned
above, a remarkable difference was observed between wild-type and
mutant full-length myosins when their actin-activated ATPase activities
were compared. As shown in Table II, the
Vmax value of actin-activated ATPase activity of
myosin was only 0.19 s
1, whereas that of the wild
type was 1.36 s
1. D403A myosin retained a medium level of
actin-activated ATPase activity (Vmax = 0.41 s
1). R402A myosin showed the normal level of
actin-activated ATPase activity. Contrary to the
Vmax values, the Km values of
actin-activated ATPase activity of wild-type and mutant myosins were
similar to each other, consistent with the notion that the myopathy
loop is involved in the strong binding of actin and myosin in the
absence of nucleotide or in the presence of ADP, not in the
weak-binding dominant in the presence of ATP. Since myosin stays in the
weak-binding state most of the time, the Km values
of the actin-activated ATPase activity mainly reflect this state. All
of these full-length myosins showed a normal level of basal MgATPase
activities, consistent with the S1 experiments as above. It seems that
hydrophobic residues in the myopathy loop are required for the full
actin-activation of the MgATPase activity of myosin. The negative
charge of Asp403 also contributed to the full activation,
which is consistent with the observation that phosphorylation of the
TEDS residue of myosin I by the heavy-chain kinase is required for the
full activation of its actin-activated ATPase activity (8). The positive charge of Arg402 did not play a role in the
activation.
|
The motor functions of the mutants were further investigated by means
of in vitro motility assays. Surprisingly,
myosin could
drive the sliding of actin filaments, although slowly. Under the
standard motility assay conditions in the presence of 0.7% methylcellulose, continuous, one-directional sliding of actin filaments
was observed. The velocity of sliding driven by
myosin was 0.2 µm/s, whereas that by the wild type was 1.2 µm/sec (Table II). In
the presence of 0.2% methylcellulose, one-directional sliding of actin
filaments was observed for a while. They then detached from the glass
surface, showing that the actin-myosin interaction was rather weak. In
the presence of a higher concentration of salt (75 mM KCl)
and 0.7% methyl cellulose, some of the filaments started
one-dimensional Brownian motion; they moved back and forth. This
behavior was not observed for sliding driven by the wild type. Thus,
the association of
myosin and actin was more dependent on the ionic
strength of the solvent than that of wild-type myosin and actin. Under
the standard motility conditions,
myosin could also exert a low
level of force on actin filaments: 4.4 piconewtons/µm of actin
filament and 32 piconewtons/µm of actin filament for mutant and
wild-type myosin, respectively (Table II).
D403A myosin drove actin filaments at a velocity of 0.5 µm/s. This
result is consistent with the observation that the
Vmax value of actin-activated ATPase activity of
D403A myosin was lower than that of the wild type (Table II). As
expected from its actin-activated ATPase activity, R402A myosin drove
the sliding of actin filaments at a similar velocity to that of the
wild type. It seems that a loss of hydrophobic residues in the
myopathy loop was mainly responsible for the slow sliding of actin
filaments driven by
myosin. Loss of a negative charge at
Asp403 partially contributed to the defects.
Effect of the Disruption of Hydrophobic Interactions on the in Vivo
Functions of Myosin--
The mutant myosins were expressed in
Dictyostelium myosin-null cells to examine if they were
functional in vivo. Transformants expressing
myosin
exhibited phenotypes very similar to those of myosin-null cells; they
neither grew in suspension nor formed fruiting bodies upon starvation.
Unlike
myosin, R402A or D403A myosin completely complemented the
phenotypic defects of myosin-null cells (data not shown). These results
suggest that hydrophobic residues in the myopathy loop are essential
for the in vivo functions of Dictyostelium myosin
II, whereas the charged residues, including the TEDS residue, are not.
| |
DISCUSSION |
|---|
|
|
|---|
It has been proposed that the
-loop-
structure at the distal
end of the lower 50-kDa subdomain interacts with the hydrophobic pocket
formed by subdomain 1 and subdomain 3 of actin (2). It has also been
proposed that the
-turn-
structure at the distal end of the upper
50-kDa subdomain, the myopathy loop, is in contact with the upper
surface of the ATP binding cleft of actin (2). Thus, in the rigor
binding, two distal ends of the upper and lower 50-kDa domains are
likely to associate with actin through hydrophobic interactions and
hold subdomain 1 of actin like two fingers holding a ball. Since
deletion of one of the hydrophobic sites, i.e. the hydrophobic residues in the myopathy loop, abolished the rigor binding
as shown here, cooperation between these two sites seems to be
essential for the tight, hydrophobic association of actin and myosin.
Consistent with this notion is the fact that replacement of one of the
conserved hydrophobic residues in the
-loop-
structure (Phe535 in Dictyostelium myosin II) with alanine
dramatically reduced the affinity of actin and
myosin.2 It must be mentioned
here that deletion of the loop abolished not only the rigor binding but
also the rigor-like binding of actin and S1 in the presence of ADP,
whereas replacement of Arg402 or Asp403 with
alanine resulted in no or only slight destabilization of the complex
under these conditions. The results show that the hydrophobic residues
in this loop contribute to the hydrophobic interface to actin in the
absence of nucleotide as well as in the presence of ADP,
i.e. in the strong-binding state during ATPase cycle.
Deletion of the loop did not completely abolish the motor functions of
myosin. The basal MgATPase activity of
myosin was activated to some
extent upon the addition of actin. Moreover, the mutant could support
the slow sliding of actin filaments and exert a low level of force on
them. The continuous, one-directional sliding of actin filaments driven
by
myosin was disrupted upon increasing the concentration of KCl in
the assay solvent from 25 to 75 mM. These results suggest
that the hydrophobic actin-myosin binding in the strong-binding state
is crucial for effective energy transduction for sliding and force
generation but not essential for these motor functions. As far as weak
ionic interactions between
myosin and actin being maintained in a
low ionic strength solvent,
myosin could support the sliding of
actin filaments and exert force on them, although at low levels. In
view of the fact that the actin-
myosin interaction was highly
dependent on the ionic strength of the solvent, this weak ionic
association of
myosin and actin must have been disrupted in the
living cells, consistent with the observation that
myosin was not
functional in Dictyostelium myosin-null cells even though it
retained a low level of in vitro motor functions.
Removal of a negative charge from the TEDS residue by D403A mutation,
which might mimic the dephosphorylation reaction, generated less severe
defects than
mutation. Consistent with the result, the mutant
myosin could completely complement the defects of myosin-null cells.
Thus, the negative charge of the TEDS residue is not essential for
in vivo and in vitro motor functions, although it
is important for the full activation of ATPase activity of myosin and
for efficient sliding of actin filaments. Removal of the positive
charge in Arg402 rarely affected motor functions. It seems
that the loss of the hydrophobic side chains was the main cause of
defects observed for
myosin and
S1. Loss of the negative charge
at Asp403 only partially contributed to the defects.
In crystal structures of the motor domain of Dictyostelium
myosin II (4, 31), the side chains of the hydrophobic residues in the
myopathy loop are fully exposed to the solvent (Fig. 1). Chicken S1 has
a similar cluster of exposed hydrophobic side chains at the
corresponding location (3). Furthermore, almost all classes of myosins
have a similar cluster of hydrophobic residues at a similar location
along their sequences, although those amino acid residues are not
conserved (10). This cluster of hydrophobic residues must be crucial
for effective actin-activation of ATPase activity, sliding of actin
filaments, and force generation.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Reiko Ohkura for her excellent technical assistance. We also thank Dr. Kazuhiro Oiwa (Kansai Advanced Research Center, Communication Research Laboratory, Japan) for providing us with Cy3-ATP.
| |
FOOTNOTES |
|---|
* This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan and a research grant from the Human Frontier Science Program (to K. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel. and Fax: 81-3-5454-6751; E-mail: sutoh@bio.c.u-tokyo.ac.jp.
2 N. Sasaki and K. Sutoh, unpublished result.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: S1, subfragment 1; MOPS, 4-morpholinepropanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Milligan, R. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
21-26 |
| 2. | Schroder, R. R., Manstein, D. J., Jahn, W., Holden, H., Rayment, I., Holmes, K. C., and Spudich, J. A. (1993) Nature 364, 171-174[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Rayment, I.,
Rypniewski, W. R.,
Schmidt, B. K.,
Smith, R.,
Tomchick, D. R.,
Benning, M. M.,
Winkelmann, D. A.,
Wesenberg, G.,
and Holden, H. M.
(1993)
Science
261,
50-58 |
| 4. | Fisher, A. J., Smith, C. A., Thoden, J. B., Smith, R., Sutoh, K., Holden, H. M., and Rayment, I. (1995) Biochemistry 34, 8960-8972[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Geisterfer, L. A., Kass, S., Tanigawa, G., Vosberg, H. P., McKenna, W., Seidman, C. E., and Seidman, J. G. (1990) Cell 62, 999-1006[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Sweeney, H. L.,
Straceski, A. J.,
Leinwand, L. A.,
Tikunov, B. A.,
and Faust, L.
(1994)
J. Biol. Chem.
269,
1603-1605 |
| 7. | Fujita, H., Sugiura, S., Momomura, S., Omata, M., Sugi, H., and Sutoh, K. (1997) J. Clin. Invest. 99, 1010-1015[Medline] [Order article via Infotrieve] |
| 8. |
Lee, S. F.,
and Cote, G. P.
(1995)
J. Biol. Chem.
270,
11776-11782 |
| 9. | Bement, W. M., and Mooseker, M. S. (1995) Cell Motil. Cytoskeleton 31, 87-92[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Mooseker, M. S., and Cheney, R. E. (1995) Annu. Rev. Cell Dev. Biol. 11, 633-675[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Sutoh, K.,
Ando, M.,
Sutoh, K.,
and Toyoshima, Y. Y.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7711-7714 |
| 12. |
Johara, M.,
Toyoshima, Y. Y.,
Ishijima, A.,
Kojima, H.,
Yanagida, T.,
and Sutoh, K.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
2127-2131 |
| 13. |
Warrick, H. M.,
De, L. A.,
Leinwand, L. A.,
and Spudich, J. A.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
9433-9437 |
| 14. |
De, L. A.,
and Spudich, J. A.
(1987)
Science
236,
1086-1091 |
| 15. | Manstein, D. J., Titus, M. A., De, L. A., and Spudich, J. A. (1989) EMBO J. 8, 923-932[Medline] [Order article via Infotrieve] |
| 16. |
O'Halloran, T. J.,
and Spudich, J. A.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
8110-8114 |
| 17. | Kubalek, E. W., Uyeda, T. Q., and Spudich, J. A. (1992) Mol. Biol. Cell 3, 1455-1462[Abstract] |
| 18. | Egelhoff, T. T., Lee, R. J., and Spudich, J. A. (1993) Cell 75, 363-371[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Uyeda, T. Q.,
and Spudich, J. A.
(1993)
Science
262,
1867-1870 |
| 20. |
Ruppel, K. M.,
Uyeda, T. Q.,
and Spudich, J. A.
(1994)
J. Biol. Chem.
269,
18773-18780 |
| 21. | Uyeda, T. Q., Ruppel, K. M., and Spudich, J. A. (1994) Nature 368, 567-569[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Chisholm, R. L.,
Rushforth, A. M.,
Pollenz, R. S.,
Kuczmarski, E. R.,
and Tafuri, S. R.
(1988)
Mol. Cell. Biol.
8,
794-801 |
| 23. |
Tafuri, S. R.,
Rushforth, A. M.,
Kuczmarski, E. R.,
and Chisholm, R. L.
(1989)
Mol. Cell. Biol.
9,
3073-3080 |
| 24. | Shimada, T., Sasaki, N., Ohkura, R., and Sutoh, K. (1997) Biochemistry 36, 14037-14043[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Sasaki, N.,
Shimada, T.,
Ohkura, R.,
and Sutoh, K.
(1998)
J. Biol. Chem.
273,
20334-20340 |
| 26. | Kron, S. J., Toyoshima, Y. Y., Uyeda, T. Q., and Spudich, J. A. (1991) Methods Enzymol. 196, 399-416[Medline] [Order article via Infotrieve] |
| 27. | Itakura, S., Yamakawa, H., Toyoshima, Y. Y., Ishijima, A., Kojima, T., Harada, Y., Yanagida, T., Wakabayashi, T., and Sutoh, K. (1993) Biochem. Biophys. Res. Commun. 196, 1504-1510[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Suzuki, Y., Ohkura, R., Sugiura, S., Yasuda, R., Kinoshita, K. J., Tanokura, M., and Sutoh, K. (1997) Biochem. Biophys. Res. Commun. 234, 701-706[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Kuhlman, P. A., and Bagshaw, C. R. (1998) J. Muscle Res. Cell Motil. 19, 491-504[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Kouyama, T., and Mihashi, K. (1981) Eur. J. Biochem. 114, 33-38[Medline] [Order article via Infotrieve] |
| 31. | Smith, C. A., and Rayment, I. (1996) Biochemistry 35, 5404-5417[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Kurzawa, S. E., Manstein, D. J., and Geeves, M. A. (1997) Biochemistry 36, 317-323[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Bagshaw, C. R., and Trentham, D. R. (1973) Biochem. J. 133, 323-328[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
H. Onishi and M. F. Morales A closer look at energy transduction in muscle PNAS, July 31, 2007; 104(31): 12714 - 12719. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, S. Shu, M. Kovacs, and E. D. Korn Biological, Biochemical, and Kinetic Effects of Mutations of the Cardiomyopathy Loop of Dictyostelium Myosin II: IMPORTANCE OF ALA400 J. Biol. Chem., July 22, 2005; 280(29): 26974 - 26983. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Patchell, C. E. Gallon, J. S. Evans, Y. Gao, S. V. Perry, and B. A. Levine The Regulatory Effects of Tropomyosin and Troponin-I on the Interaction of Myosin Loop Regions with F-actin J. Biol. Chem., April 15, 2005; 280(15): 14469 - 14475. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takeshita, A. Ohta, and H. Horiuchi CsmA, a Class V Chitin Synthase with a Myosin Motor-like Domain, Is Localized through Direct Interaction with the Actin Cytoskeleton in Aspergillus nidulans Mol. Biol. Cell, April 1, 2005; 16(4): 1961 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sasaki, R. Ohkura, and K. Sutoh Insertion or Deletion of a Single Residue in the Strut Sequence of Dictyostelium Myosin II Abolishes Strong Binding to Actin J. Biol. Chem., December 1, 2000; 275(49): 38705 - 38709. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |